Stroma biglycan expression can be a prognostic factor in prostate cancers.
Jun FurumidoNako MaishiAya Yanagawa-MatsudaHiroshi KikuchiRyuji MatsumotoTakahiro OsawaTakashige AbeYoshihiro MatsunoNobuo ShinoharaYasuhiro HidaKyoko HidaPublished in: International journal of urology : official journal of the Japanese Urological Association (2022)
This is the first study to show that stroma biglycan is a useful prognostic factor for prostate cancer.